ImageneBio Inc (IMA)

• Market cap: $78.4M
• 1 day: -0.14%
• 5 days: -5.27%
• 1 month: 9.36%
• 3 months: -14.72%
• 6 months: -57.49%
• Year to date: 3.7%
• 1 year: -59.99%
• 5 years: -98.17%
• 10 years: -98.17%
• Sector: Healthcare
• Industry: Biotechnology

About: ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.

Employees: 15